学术探索
学术期刊
新闻热点
数据分析
智能评审

Three new cases of non-Hodgkin lymphoma with t(9;14)(p13;q32)

被引：10
作者：
Andrieux, J
Fert-Ferrer, S
Copin, MC
Huyghe, P
Pocachard, P
Lespinasse, J
Bauters, F
Lai, JL
Quesnel, B
机构：
[1] Ctr Hosp Reg & Univ Lille, Hop Jeanne de Flandre, Med Genet Lab, F-59037 Lille, France
[2] INSERM, U524, F-59045 Lille, France
[3] CH, Lab Genet Chromosom, Chambery, France
[4] CHRU, Hop Calmette, Lab Anat & Cytol Pathol, Lille, France
[5] CHRU, Serv Malad Sang, Lille, France
[6] CH, Lab Anat & Cytol Pathol, Chambery, France
来源：
CANCER GENETICS AND CYTOGENETICS | 2003年 / 145卷 / 01期
关键词：
D O I：
10.1016/S0165-4608(03)00054-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The majority of non-Hodgkin lymphomas of B-cell type (B-NHL) exhibit chromosomal abnormalities including, many types of reciprocal translocations closely related to specific histopathologic entities. The t(9;14)(p13;q32) has been recognized as a primary genetic event directly involved in the development of lymphoplasmacytic lymphoma. In the 14 published cases, the t(9;14)(p13;32) seems to delineate a variety of low-grade B-cell disorders characterized by a common clinical history and immunopathologic similarities. We report here three new cases presenting a t(9;14)(p13;q32) with other chromosomal abnormalities which have been referred to as B-cell low-grade or high-grade malignant lymphoproliferative disorders. Two of these cases showed diffuse large B cell lymphoma morphology and two patients had a favorable clinical outcome. These data suggest that t(9;14)(p13-.q32) is not restricted to low-grade lymphoma. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码：65 / 69
页数：5
相关论文
共 22 条
[1]   PAX-5 ENCODES THE TRANSCRIPTION FACTOR BSAP AND IS EXPRESSED IN LYMPHOCYTES-B, THE DEVELOPING CNS, AND ADULT TESTIS [J].
ADAMS, B ;
DORFLER, P ;
AGUZZI, A ;
KOZMIK, Z ;
URBANEK, P ;
MAURERFOGY, I ;
BUSSLINGER, M .
GENES & DEVELOPMENT, 1992, 6 (09) :1589-1607
[2]  
Amakawa R, 1999, INT J HEMATOL, V69, P65
[3]  
Avet-Loiseau H, 1999, GENE CHROMOSOME CANC, V24, P9, DOI 10.1002/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO
[4]  
2-K
[5]   Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia:: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique [J].
Avet-Loiseau, H ;
Daviet, A ;
Brigaudeau, C ;
Callet-Bauchu, E ;
Terré, C ;
Lafage-Pochitaloff, M ;
Désangles, F ;
Ramond, S ;
Talmant, P ;
Bataille, R .
BLOOD, 2001, 97 (03) :822-825
[6]   CYTOGENETIC STUDIES IN 4 CASES OF ALPHA-CHAIN DISEASE [J].
BERGER, R ;
BERNHEIM, A ;
TSAPIS, A ;
BROUET, JC ;
SELIGMANN, M .
CANCER GENETICS AND CYTOGENETICS, 1986, 22 (03) :219-223
[7]   Deregulation of PAX-5 by translocation of the E mu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma [J].
Busslinger, M ;
Klix, N ;
Pfeffer, P ;
Graninger, PG ;
Kozmik, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :6129-6134
[8]   Deletion 7q in B-cell low-grade lymphoid malignancies:: A cytogenetic/fluorescence in situ hybridization and immunopathologic study [J].
Dascalescu, CM ;
Péoc'h, M ;
Callanan, M ;
Jacob, MC ;
Sotto, MF ;
Gressin, R ;
Sotto, JJ ;
Leroux, D .
CANCER GENETICS AND CYTOGENETICS, 1999, 109 (01) :21-28
[9]   The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells [J].
Emelyanov, AV ;
Kovac, CR ;
Sepulveda, MA ;
Birshtein, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11156-11164
[10]  
Hamada T, 1998, BRIT J HAEMATOL, V102, P691
123